These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1148708)

  • 1. Letter: Predictive value of hydroxyproline: creatinine ratio in advanced breast cancer.
    Roberts JG; Baum M
    Br Med J; 1975 Jun; 2(5970):559. PubMed ID: 1148708
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological markers as prognostic and clinical evaluation tools.
    Tormey DC; Waalkes TP
    Eur J Cancer (1965); 1980; Suppl 1():21-4. PubMed ID: 7032933
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hydroxyproline in the diagnosis of bone metastases in breast cancer].
    Gasser AB; Depierre D; Alberto P; Courvoisier B
    Schweiz Med Wochenschr; 1977 Jul; 107(28):984-6. PubMed ID: 897640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyproline excretion in patients with breast cancer and response to treatment.
    Powles TJ; Leese CL; Bondy PK
    Br Med J; 1975 Apr; 2(5964):164-6. PubMed ID: 1125725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Variable behavior of urinary hydroxyproline in breast cancer with osseous metastases].
    Polico C; Nascimben O; Maccari F; Fazzin G
    Quad Sclavo Diagn; 1978 Dec; 14(4):486-93. PubMed ID: 757622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of urinary hydroxyproline and bone isoenzyme of alkaline phosphatase in the early detection and follow-up of bone metastasis in breast cancer patients.
    Frenay M; Namer M; Boublil JL; Khater R; Viot M; François E; Milano G
    Bull Cancer; 1988; 75(6):533-9. PubMed ID: 3416085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leucocyte ascorbic acid and urinary hydroxyproline levels in patients bearing breast cancer with skeletal metastases.
    Basu TK; Raven RW; Dickerson JW; Williams DC
    Eur J Cancer (1965); 1974 Aug; 10(8):507-11. PubMed ID: 4463001
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experiences with tamoxifen for estrogen receptor blocking therapy in metastatic breast cancer.
    Henningsen B
    Prog Clin Biol Res; 1977; 12():479-82. PubMed ID: 918118
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary hydroxyproline excretion in carcinoma of the breast.
    Cuschieri A; Felgate RA
    Br J Exp Pathol; 1972 Jun; 53(3):237-41. PubMed ID: 5055709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy of metastatic breast cancer.
    Bessler WT
    Prog Clin Biol Res; 1977; 12():493-504. PubMed ID: 411138
    [No Abstract]   [Full Text] [Related]  

  • 11. Norethisterone acetate (SH420) in advanced breast cancer.
    Edelstyn GA
    Cancer; 1973 Dec; 32(6):1317-20. PubMed ID: 4757921
    [No Abstract]   [Full Text] [Related]  

  • 12. Norethisterone acetate in the treatment of advanced breast cancer.
    Rubens RD; Knight RK; Hayward JL
    Eur J Cancer (1965); 1976 Jul; 12(7):563-5. PubMed ID: 954799
    [No Abstract]   [Full Text] [Related]  

  • 13. The hypronosticon test in breast cancer.
    Roberts JG; Williams M; Henk JM; Bligh AS; Baum M
    Clin Oncol; 1975 Mar; 1(1):33-43. PubMed ID: 1204270
    [No Abstract]   [Full Text] [Related]  

  • 14. Association between vasopressin and corticosteroids in the palliative treatment of advanced breast cancer.
    Bernard-Weil E; Pilleron JP
    Oncology; 1973; 28(6):492-508. PubMed ID: 4129456
    [No Abstract]   [Full Text] [Related]  

  • 15. Postabsorptive urinary hydroxyproline test in patients with metastatic bone disease from breast cancer.
    Niell HB; Palmieri GM; Neely CL; McDonald MW
    Arch Intern Med; 1981 Oct; 141(11):1471-3. PubMed ID: 7283558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium metabolism in breast cancer.
    Coombes RC; Powles TJ; Joplin DG
    Proc R Soc Med; 1977 Mar; 70(3):195-9. PubMed ID: 870901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of advanced mammary cancer.
    Welbourn RB; Burn JI
    N Engl J Med; 1972 Aug; 287(8):398-400. PubMed ID: 5043525
    [No Abstract]   [Full Text] [Related]  

  • 18. 'Early' breast cancer, bone scanning, and the urinary excretion of hydroxyproline.
    Sumner DS; Baum M; Parsons V; Edwards MH
    Br J Surg; 1973 Apr; 60(4):306. PubMed ID: 4700234
    [No Abstract]   [Full Text] [Related]  

  • 19. [Urinary hydroxyproline in advanced breast carcinoma and response to treatment with medroxyprogesterone acetate (MAP) in high doses].
    Martoni A; Pedelini G; Colalongo G; Biagi R; Mambelli M; Jafelice G; Rocchetta G; Piana E; Pannuti F
    Minerva Med; 1980 Sep; 71(31):2215-9. PubMed ID: 7422143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary hydroxyproline and cancer of the breast].
    Bellido V; Carda P; Mascías E
    Rev Esp Oncol; 1983; 30(1):7-16. PubMed ID: 6679910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.